Cargando…

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid accumulation in the liver which is not due to alcohol use, has emerged as one of the major health problems around the world. The dysregulated lipid metabolism creates a lipotoxic environment which promotes the devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Yana, Faber, Klaas Nico, de Meijer, Vincent E., Blokzijl, Hans, Moshage, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886759/
https://www.ncbi.nlm.nih.gov/pubmed/33548031
http://dx.doi.org/10.1007/s12072-020-10121-2
_version_ 1783651864906039296
author Geng, Yana
Faber, Klaas Nico
de Meijer, Vincent E.
Blokzijl, Hans
Moshage, Han
author_facet Geng, Yana
Faber, Klaas Nico
de Meijer, Vincent E.
Blokzijl, Hans
Moshage, Han
author_sort Geng, Yana
collection PubMed
description BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid accumulation in the liver which is not due to alcohol use, has emerged as one of the major health problems around the world. The dysregulated lipid metabolism creates a lipotoxic environment which promotes the development of NAFLD, especially the progression from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH). PURPOSEAND AIM: This review focuses on the mechanisms of lipid accumulation in the liver, with an emphasis on the metabolic fate of free fatty acids (FFAs) in NAFLD and presents an update on the relevant cellular processes/mechanisms that are involved in lipotoxicity. The changes in the levels of various lipid species that result from the imbalance between lipolysis/lipid uptake/lipogenesis and lipid oxidation/secretion can cause organellar dysfunction, e.g. ER stress, mitochondrial dysfunction, lysosomal dysfunction, JNK activation, secretion of extracellular vesicles (EVs) and aggravate (or be exacerbated by) hypoxia which ultimately lead to cell death. The aim of this review is to provide an overview of how abnormal lipid metabolism leads to lipotoxicity and the cellular mechanisms of lipotoxicity in the context of NAFLD.
format Online
Article
Text
id pubmed-7886759
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-78867592021-03-03 How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Geng, Yana Faber, Klaas Nico de Meijer, Vincent E. Blokzijl, Hans Moshage, Han Hepatol Int Review Article BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid accumulation in the liver which is not due to alcohol use, has emerged as one of the major health problems around the world. The dysregulated lipid metabolism creates a lipotoxic environment which promotes the development of NAFLD, especially the progression from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH). PURPOSEAND AIM: This review focuses on the mechanisms of lipid accumulation in the liver, with an emphasis on the metabolic fate of free fatty acids (FFAs) in NAFLD and presents an update on the relevant cellular processes/mechanisms that are involved in lipotoxicity. The changes in the levels of various lipid species that result from the imbalance between lipolysis/lipid uptake/lipogenesis and lipid oxidation/secretion can cause organellar dysfunction, e.g. ER stress, mitochondrial dysfunction, lysosomal dysfunction, JNK activation, secretion of extracellular vesicles (EVs) and aggravate (or be exacerbated by) hypoxia which ultimately lead to cell death. The aim of this review is to provide an overview of how abnormal lipid metabolism leads to lipotoxicity and the cellular mechanisms of lipotoxicity in the context of NAFLD. Springer India 2021-02-06 /pmc/articles/PMC7886759/ /pubmed/33548031 http://dx.doi.org/10.1007/s12072-020-10121-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review Article
Geng, Yana
Faber, Klaas Nico
de Meijer, Vincent E.
Blokzijl, Hans
Moshage, Han
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
title How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
title_full How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
title_fullStr How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
title_full_unstemmed How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
title_short How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
title_sort how does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886759/
https://www.ncbi.nlm.nih.gov/pubmed/33548031
http://dx.doi.org/10.1007/s12072-020-10121-2
work_keys_str_mv AT gengyana howdoeshepaticlipidaccumulationleadtolipotoxicityinnonalcoholicfattyliverdisease
AT faberklaasnico howdoeshepaticlipidaccumulationleadtolipotoxicityinnonalcoholicfattyliverdisease
AT demeijervincente howdoeshepaticlipidaccumulationleadtolipotoxicityinnonalcoholicfattyliverdisease
AT blokzijlhans howdoeshepaticlipidaccumulationleadtolipotoxicityinnonalcoholicfattyliverdisease
AT moshagehan howdoeshepaticlipidaccumulationleadtolipotoxicityinnonalcoholicfattyliverdisease